Inhibiting cytoplasmic accumulation of HuR synergizes genotoxic agents in urothelial carcinoma of the bladder

HuR, an RNA-binding protein, post-transcriptionally regulates nearly 4% of encoding proteins implicated in cell survival. Here we show that HuR is required for the efficacy of chemotherapies in urothelial carcinoma of the bladder. We identify pyrvinium pamoate, an FDA-approved anthelminthic drug, as...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Guo, Jiawei, Lv, Jing, Chang, Siyu, Chen, Zhi, Lu, Weiqiang, Xu, Chuanliang, Liu, Mingyao, Pang, Xiufeng
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2016
Sujets:
Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5216720/
https://ncbi.nlm.nih.gov/pubmed/27303922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9932
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires